Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hansson

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Journal of Medical Genetics|August 15, 2006
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsAlisa M Goldstein, May Chan, Mark Harland, et al.
Nature Genetics|October 14, 2008
Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traitsSimon N Stacey, Daniel F Gudbjartsson, Patrick Sulem, et al.
Journal of the American Academy of Dermatology|February 8, 2019
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICTNicholas J Taylor, Nandita Mitra, Lu Qian, et al.
The Lancet. Oncology|June 5, 2019
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trialElisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, et al.
Nature Genetics|May 20, 2008
Common sequence variants on 20q11.22 confer melanoma susceptibilityKevin M Brown, Stuart Macgregor, Grant W Montgomery, et al.
Cancer Research|October 19, 2006
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMELAlisa M Goldstein, May Chan, Mark Harland, et al.
International Journal of Cancer|August 1, 2014
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regionsJennifer H Barrett, John C Taylor, Chloe Bright, et al.
The Journal of Investigative Dermatology|August 24, 2017
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma FamiliesNicholas J Taylor, Nandita Mitra, Alisa M Goldstein, et al.
The Journal of Investigative Dermatology|February 2, 2016
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma FamiliesNicholas J Taylor, Elizabeth A Handorf, Nandita Mitra, et al.
Oncotarget|May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancerVladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Journal of Medical Genetics|August 15, 2006
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsAlisa M Goldstein, May Chan, Mark Harland, et al.
Nature Genetics|October 14, 2008
Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traitsSimon N Stacey, Daniel F Gudbjartsson, Patrick Sulem, et al.
Journal of the American Academy of Dermatology|February 8, 2019
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICTNicholas J Taylor, Nandita Mitra, Lu Qian, et al.
The Lancet. Oncology|June 5, 2019
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trialElisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, et al.
Nature Genetics|May 20, 2008
Common sequence variants on 20q11.22 confer melanoma susceptibilityKevin M Brown, Stuart Macgregor, Grant W Montgomery, et al.
Cancer Research|October 19, 2006
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMELAlisa M Goldstein, May Chan, Mark Harland, et al.
International Journal of Cancer|August 1, 2014
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regionsJennifer H Barrett, John C Taylor, Chloe Bright, et al.
The Journal of Investigative Dermatology|August 24, 2017
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma FamiliesNicholas J Taylor, Nandita Mitra, Alisa M Goldstein, et al.
The Journal of Investigative Dermatology|February 2, 2016
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma FamiliesNicholas J Taylor, Elizabeth A Handorf, Nandita Mitra, et al.
Oncotarget|May 7, 2015
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancerVladimir Lazar, Eitan Rubin, Stephane Depil, et al.
Pageof 20